TWO SIGMA ADVISERS, LP - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 60 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$1,269,570
-38.6%
251,400
-38.9%
0.00%
-40.0%
Q2 2023$2,069,342
-42.4%
411,400
-29.6%
0.01%
-44.4%
Q1 2023$3,594,060
-51.3%
584,400
+4.5%
0.01%
-57.1%
Q4 2022$7,381,440
+502.6%
559,200
+35.6%
0.02%
+425.0%
Q3 2022$1,225,000
-38.2%
412,531
-24.1%
0.00%
-33.3%
Q2 2022$1,983,000
-39.8%
543,300
+2.1%
0.01%
-33.3%
Q1 2022$3,295,000
-22.8%
532,300
+1.0%
0.01%
-18.2%
Q4 2021$4,268,000
-40.1%
526,900
+10.1%
0.01%
-38.9%
Q3 2021$7,128,000
+10700.0%
478,400
+1358.5%
0.02%
Q2 2020$66,00032,8000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q3 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders